Literature DB >> 15277072

A randomized, controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd.

L L Kulichenko1, L V Kireyeva, E N Malyshkina, G Wikman.   

Abstract

Two randomized, parallel-group clinical studies with a verum and a control group were performed to investigate the effect of a standardized extract (SHA-10) of Andrographis panaiculata (N.) fixed combination Kan Jang in the treatment of diagnosed influenza viral infection. The pilot study was performed on 540 patients with 71 Kan Jang-treated patients with the second phase conducted enrolling 66 patients. The differences in the duration of sick leave and frequency of post-influenza complications indicate that the Kan Jang phytopreparation not only contributes to quicker recovery, but also reduces the risk of post-influenza complications. Kan Jang was well tolerated by patients.

Entities:  

Year:  2003        PMID: 15277072

Source DB:  PubMed          Journal:  J Herb Pharmacother        ISSN: 1522-8940


  11 in total

1.  Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells.

Authors:  Sangeetha Sukumari-Ramesh; J Nicole Bentley; Melissa D Laird; Nagendra Singh; John R Vender; Krishnan M Dhandapani
Journal:  Int J Dev Neurosci       Date:  2011-06-17       Impact factor: 2.457

Review 2.  Nain-e Havandi Andrographis paniculata present yesterday, absent today: a plenary review on underutilized herb of Iran's pharmaceutical plants.

Authors:  Alireza Valdiani; Mihdzar Abdul Kadir; Soon Guan Tan; Daryush Talei; Mohd Puad Abdullah; Sonia Nikzad
Journal:  Mol Biol Rep       Date:  2011-12-24       Impact factor: 2.316

Review 3.  Amantadine and rimantadine for influenza A in children and the elderly.

Authors:  Márcia G Alves Galvão; Marilene Augusta Rocha Crispino Santos; Antonio J L Alves da Cunha
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

Review 4.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

5.  A Herbal Composition of Scutellaria baicalensis and Eleutherococcus senticosus Shows Potent Anti-Inflammatory Effects in an Ex Vivo Human Mucosal Tissue Model.

Authors:  Nan Zhang; Koen Van Crombruggen; Gabriele Holtappels; Claus Bachert
Journal:  Evid Based Complement Alternat Med       Date:  2012-01-05       Impact factor: 2.629

Review 6.  Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis.

Authors:  Xiao-Yang Hu; Ruo-Han Wu; Martin Logue; Clara Blondel; Lily Yuen Wan Lai; Beth Stuart; Andrew Flower; Yu-Tong Fei; Michael Moore; Jonathan Shepherd; Jian-Ping Liu; George Lewith
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

Review 7.  Andrographis paniculata (Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy.

Authors:  Sanower Hossain; Zannat Urbi; Hidayah Karuniawati; Ramisa Binti Mohiuddin; Ahmed Moh Qrimida; Akrm Mohamed Masaud Allzrag; Long Chiau Ming; Ester Pagano; Raffaele Capasso
Journal:  Life (Basel)       Date:  2021-04-16

8.  Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study.

Authors:  Mikayel Narimanyan; Kristina Jamalyan; Anna Balyan; Anders Barth; Staffan Palm; Georg Wikman; Alexander Panossian
Journal:  J Tradit Complement Med       Date:  2021-06-11

Review 9.  A comprehensive review on disposition kinetics and dosage of oral administration of Andrographis paniculata, an alternative herbal medicine, in co-treatment of coronavirus disease.

Authors:  Phanit Songvut; Tawit Suriyo; Duangchit Panomvana; Nuchanart Rangkadilok; Jutamaad Satayavivad
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

10.  Efficacy of Kan Jang® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial.

Authors:  Levan Ratiani; Elene Pachkoria; Nato Mamageishvili; Ramaz Shengelia; Areg Hovhannisyan; Alexander Panossian
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.